Connection

FILIP JANKU to Wnt Signaling Pathway

This is a "connection" page, showing publications FILIP JANKU has written about Wnt Signaling Pathway.
Connection Strength

0.040
  1. Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours. Br J Cancer. 2021 07; 125(1):28-37.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.